Pathogenic Effector Th2 Cells in Allergic Eosinophilic Inflammatory Disease

Overview of attention for article published in Frontiers in Medicine, October 2017

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 4,378 followers.

To understand how mepolizumab and tezepelumab work in asthma & other lung diseases @EU_COPD read @FrontMedicine https://t.co/lxQZQL7umG

Pathogenic Effector Th2 Cells in Allergic Eosinophilic Inflammatory Disease: Alyssa Mitson-Salazar, Calman Prussin https://t.co/dWVZODvOxv

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.